GlassScriptPhysician profile
Brandon A Doser
NPI 1811284680
$7,226.13
in general payments reported to CMS, 2019-2025
13 companies · $1,324 in 2025
The $1,324 reported for 2025 was more than what 75% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $258 · 2020: $14.56 · 2021: $1,530 · 2022: $808 · 2023: $1,893 · 2024: $1,398 · 2025: $1,324.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,951 · Travel and Lodging: $1,663.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,951.48 |
| Travel and Lodging | $1,663.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $4,743.32 | 2019-2025 | Infinity, Prophecy, Prostep |
| Elite Orthopedics, LLC | $2,147.33 | 2021-2025 | |
| Vertex Pharmaceuticals Incorporated | $62.62 | 2025 | |
| Arthrex, INC. | $45.36 | 2022-2023 | Distal Extremities Implants Foot & Ankle Metal Compression Screws |
| Bioventus LLC | $43.64 | 2025 | Exogen Ultrasound Bone Healing System |
| Solventum Corporation | $30.15 | 2025 | Prevena, V.A.C. Veraflo Cleanse Choice |
| Wright Medical Technology, INC. | $28.02 | 2019-2020 | |
| Convatec INC. | $24.82 | 2025 | |
| Depuy Synthes Sales INC. | $21.83 | 2024 | Monovisc |
| Medtronic, INC. | $21.68 | 2024 | Intellis Adaptivestim |
| Organogenesis INC. | $20.46 | 2023 | Puraply |
| Takeda Pharmaceuticals U.S.A., INC. | $20.39 | 2025 | Entyvio |
| Pacira Pharmaceuticals Incorporated | $16.51 | 2024 | Iovera |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandon Doser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.